Clinical Trial

New AI-based Technologies in Nuclear Medicine

Study acronym: AI-basedMedNuc
Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to identify and predict radiopharmaceutical extravasation events using new semi-quantitative parameters and machine learning models. It involves dose rate measurements to develop metrics for real-time monitoring. It also investigates the correlation between extravasation and SUV correction in PET/CT diagnostics, providing an estimate of the correction factor necessary for accurate SUV evaluation in case of an extravasation event.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-11.
Trial Details
NCT Number NCT07174089
Lead Sponsor Azienda USL Reggio Emilia - IRCCS
Conditions Patients Undergoing PET/CT Investigation or Nuclear Medicine Therapy
Enrollment 1,500 participants
Start Date 2021-07-30
Primary Completion 2022-09-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-29